Galaxy Surfactants Ltd. (GALAXYSURF) AI Stock Analysis

• Market Cap: ₹58.18B
• Dividend Yield: 1.07%
• Average Volume (3M): 465.00
• Price to Earnings (P/E): 30.8
• Beta (1Y): 0.83
• Revenue Growth: 22.63%
• EPS Growth: -8.57%
• Country: IN
• Employees: 1,762
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Chemicals - Specialty
• EPS (TTM): 16.60
• Shares Outstanding: 35,454,754
• 10 Day Avg. Volume: 455
• 30 Day Avg. Volume: 465
• PEG Ratio: 21.32
• Price to Book (P/B): 3.14
• Price to Sales (P/S): 1.76
• P/FCF Ratio: 31.35
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹2,647.00
• Price Target Upside: 35.00% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 81.89
• Revenue Forecast (FY): ₹51.82B

• Rating: 60 Neutral
• Price Target: ₹1,723.00 ▼(-12.12% Downside)
• Action: Reiterated Date: 12/02/25
• Date: Action: Reiterated 12/02/25

Galaxy Surfactants Ltd. has a strong financial foundation, which is a significant positive factor. However, the technical analysis indicates bearish momentum, which is a major concern. The valuation is moderate, offering a balanced view. The absence of earnings call data and corporate events limits additional insights.

Positive Factors

Consistent revenue and profit growth

Sustained revenue and solid gross/net margins indicate durable demand and pricing power in specialty surfactants. This supports reinvestment in product development, scale-driven cost advantages, and resilience to raw-material swings, underpinning medium-term profitability and strategic growth.

Solid balance sheet and low leverage

A conservative capital structure and strong equity position provide financial flexibility for capex, working capital and selective M&A. Low leverage reduces refinancing risk through cycles, enabling stable investment in specialty capabilities and supporting long-term operational continuity.

Strong operating cash flow and positive FCF

Robust cash generation funds R&D, capacity expansion and shareholder returns without over-reliance on debt. Positive free cash flow enables strategic investment in higher-value specialty grades and cushions the business against commodity cost volatility, supporting sustainable competitive positioning.

Negative Factors

Negative EPS growth

A decline in EPS signals near-term pressure on profitability which, if persistent, can weaken returns to shareholders and reduce retained earnings for reinvestment. For a specialty chemicals firm, sustained EPS erosion can hinder funding for innovation and capacity upgrades essential to defend margins.

Slight decline in recent FCF growth

Even with positive FCF, a downward trend reduces the cushion for capital allocation and increases sensitivity to raw-material or demand shocks. If not addressed, slowing FCF growth can constrain expansion into higher-margin products or raise reliance on external financing for strategic projects.

Undisclosed customer/contract concentration

Lack of disclosure on customer or contract concentration hides revenue risk profile; high concentration to a few brand owners would increase vulnerability to lost contracts or pricing pressure. Transparency here matters for assessing sustainable revenue and renewal risk over time.

Galaxy Surfactants Ltd. Business Overview & Revenue Model

Company Description

Galaxy Surfactants Limited manufactures and markets specialty chemicals for personal and home care industries in India and internationally. The company offers fatty alcohol surfactants, fatty alcohol ethoxylates, alkyl benzene sulphonic acids, foam and viscosity boosters, mild surfactants, pearlizers, surfactant blends, syndet and TBB, sunscreens, preservatives, and blends, as well as emollients, conditioning agents, hair color protector, scalp care, and anti-microbials. It serves the skin, hair, sun, oral, baby, and home care markets. The company was founded in 1980 and is based in Navi Mumbai, India.

How the Company Makes Money

Galaxy Surfactants primarily makes money by manufacturing and selling specialty chemical ingredients—mainly surfactants and related performance ingredients—used by home and personal care companies and other formulators. Revenue is generated from (1) product sales across end-use segments (notably home care and personal care), where customers purchase these ingredients as formulation inputs; (2) supplying a portfolio of surfactant chemistries and associated products tailored to customer specifications and application performance requirements, which supports repeat purchasing as customers run production cycles; and (3) geographic mix of domestic and export sales, with earnings influenced by volumes sold, product mix (higher value-added specialty grades versus more commodity-like products), and pass-through/management of key raw-material price movements typical in surfactant value chains. Specific details on major partnerships, customer concentration, segment-wise revenue split, or contract structures are null.

Galaxy Surfactants Ltd. Financial Statement Overview

Summary

Galaxy Surfactants Ltd. demonstrates strong financial health with consistent revenue and profit growth, prudent financial leverage, and robust cash flow management. The company is well-positioned within the specialty chemicals industry, though monitoring cash flow trends is crucial.

Income Statement

Galaxy Surfactants Ltd. has shown consistent revenue growth, with a notable increase in total revenue from 2024 to 2025. The gross profit and net profit margins are strong, indicating efficient cost management and profitability. EBIT and EBITDA margins are healthy, supporting a robust operating performance.

Balance Sheet

The company maintains a solid equity base, with a strong equity ratio indicating financial stability. The debt-to-equity ratio is low, suggesting conservative leverage. The return on equity is favorable, reflecting effective utilization of shareholder funds. Overall, the balance sheet is stable with a healthy equity position.

Cash Flow

Operating cash flows are strong, with a positive free cash flow trajectory. The free cash flow to net income ratio is favorable, indicating efficient cash management. However, a slight decline in free cash flow growth in the past year suggests areas needing attention.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	47.91B	42.24B	37.65B	44.45B	36.53B	27.45B
Gross Profit	13.21B	13.38B	11.58B	13.16B	10.44B	9.55B
EBITDA	4.87B	4.84B	4.98B	5.75B	4.11B	4.58B
Net Income	2.86B	3.05B	3.01B	3.81B	2.63B	3.02B
Balance Sheet
Total Assets	37.78B	34.62B	29.15B	27.34B	26.01B	20.49B
Cash, Cash Equivalents and Short-Term Investments	6.55B	5.00B	4.38B	2.47B	692.40M	1.54B
Total Debt	2.68B	2.10B	1.87B	3.27B	4.21B	2.89B
Total Liabilities	12.43B	11.00B	7.35B	8.52B	10.26B	7.48B
Stockholders Equity	25.35B	23.63B	21.79B	18.83B	15.74B	13.01B
Cash Flow
Free Cash Flow	993.10M	2.37B	3.60B	4.27B	-1.50B	2.58B
Operating Cash Flow	1.69B	4.21B	5.18B	5.73B	49.30M	3.65B
Investing Cash Flow	-1.11B	-2.95B	-3.44B	-1.49B	-841.20M	-1.65B
Financing Cash Flow	53.10M	-1.57B	-1.89B	-2.64B	591.50M	-1.65B

Galaxy Surfactants Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1960.70
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:GALAXYSURF, the sentiment is Negative. The current price of 1960.7 is above the 20-day moving average (MA) of 1857.76, above the 50-day MA of 1877.43, and below the 200-day MA of 2193.98, indicating a bearish trend. The MACD of -62.27 indicates Positive momentum. The RSI at 27.68 is Positive, neither overbought nor oversold. The STOCH value of 8.12 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:GALAXYSURF.

Galaxy Surfactants Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PGHL	73 Outperform	₹80.85B	30.50	―	3.28%	3.01%	22.98%
ZYDUSWELL	66 Neutral	₹135.14B	-90.62	―	0.28%	14.55%	-20.61%
JYOTHYLAB	64 Neutral	₹76.60B	31.99	―	1.24%	1.62%	-7.32%
MANORAMA	64 Neutral	₹76.01B	27.59	―	0.04%	89.51%	188.01%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
GALAXYSURF	60 Neutral	₹58.18B	30.80	―	1.07%	22.63%	-8.57%
HONASA	54 Neutral	₹94.15B	46.47	―	―	10.59%	67.55%

Galaxy Surfactants Ltd. Corporate Events

Galaxy Surfactants Schedules Investor Conference Meetings for February 25

Galaxy Surfactants Ltd. has announced that its officials will participate in an investor conference organized by IIFL Capital on February 25, 2026, in Mumbai, with the meetings scheduled to take place in person during the afternoon. The company stated that discussions with analysts and institutional investors will be restricted to publicly available information, with no unpublished price sensitive information to be shared, and noted that the schedule may change due to exigencies from the host or the company.